Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Class ASSE: 600613

Report for Q3 2024

· Issued by Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Class A via Shanghai Stock Exchange
Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment